Sign inJoin waitlistJoin the waitlist

John Christodouleas

Adjunct Associate Professor · University of Pennsylvania Health System

Credentials: · · · · ·

History

University of Pennsylvania Health System
Present

Lemuel Shattuck Hospital
2009–2014
Radiation Oncology
Johns Hopkins Hospital
2005–2009
Preliminary or Transitional Year
2004–2005
Tufts University School of Medicine
2000–2004
Swarthmore College
1994–1998

Research

Magnetic Resonance Imaging-Guided Adaptive Radiation Therapy: A "Game Changer" for Prostate Treatment?
Review · International journal of radiation oncology · 2018 · 146 citations
The MOMENTUM Study: An International Registry for the Evidence-Based Introduction of MR-Guided Adaptive Therapy
Frontiers in Oncology · 2020 · 136 citations
Short-term and long-term health risks of nuclear-power-plant accidents
Review · New England Journal of Medicine · 2011 · First of 6 authors · 92 citations

Justin Bekelman
26 papers · 12 as a resident
Neha Vapiwala
26 papers · 7 as a resident
BB
Brian Baumann
25 papers · 18 as a resident
Clifton Fuller
20 papers
Curtiland Deville
19 papers
Thomas Guzzo
18 papers
AM
Abdallah Mohamed
15 papers
Kareem Wahid
12 papers
Bruce Malkowicz
9 papers
ZT
Zelig Tochner
9 papers
David Vaughn
8 papers
Peter Gabriel
8 papers

Grants

Development of Functional Magnetic Resonance Imaging-Guided Adaptive Radiotherapy for Head and Neck Cancer Patients Using Novel MR-Linac Device
National Institute of Dental and Craniofacial Research · R01
PI · $4.3M · University of Tx Md Anderson Can Ctr
2019–2026

Clinical trials

Adjuvant Concurrent Immunotherapy and Radiotherapy for the Treatment of Bladder Cancer
Principal investigator · Recruiting · Phase 1
Abramson Cancer Center at Penn Medicine
2025–2027
Neutrophil-to-Lymphocyte Ratio in Bladder Cancer: A Secondary Biomarker Analysis of SWOG 8710
Principal investigator · Completed
Abramson Cancer Center at Penn Medicine
2016
Initial Evaluation of a Telomerase-based Circulating Tumor Cell Assay in Bladder Cancer Cohorts
Principal investigator · Completed
Abramson Cancer Center at Penn Medicine
2014–2020
Proton Therapy for High Risk Prostate Cancer
Principal investigator · Withdrawn
Abramson Cancer Center at Penn Medicine
2013–2014